Letter | Published:

Regulation of leukocyte migration by activation of the leukocyte adhesion molecule-1 (LAM-1) selectin

Abstract

A CENTRAL feature of host defence is the ability of leukocytes to enter tissues in response to immune or inflammatory stimuli. The leukocyte adhesion molecule-1 (LAM-1) regulates the migration of human leukocytes by mediating the binding both of lymphocytes to high endothelial venules of peripheral lymph nodes and of neutrophils to endothelium at inflammatory sites1–10. As lymphocytes and neutrophils express the same LAM-1 protein11,12, it is not clear how lineage-specific differences in leukocyte migration are controlled. We now report that the affinity of LAM-1 for a carbohydrate-based ligand, PPME13–16, is dramatically increased following lymphocyte and neutrophil activation by lineage-specific stimuli. In addition, activation of lymphocytes by physiological stimuli enhanced LAM-1-dependent binding to high endothelial venules. Thus, transient changes in LAM-1 affinity after leukocyte stimulation probably directly influence leukocyte migration.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1

    Stoolman, L. M. Cell 56, 907–910 (1989).

  2. 2

    Tedder, T. F. et al. J. exp. Med. 170, 123–133 (1989).

  3. 3

    Tedder, T. F., Penta, A. C., Levine, H. B. & Freedman, A. S. J. Immun. 144, 532–540 (1990).

  4. 4

    Bowen, B. R., Nguyen, T. & Lasky, L. A. J. Cell Biol. 109, 421–427 (1989).

  5. 5

    Siegelman, M. H. & Weissman, I. L. Proc. natn. Acad. Sci. U.S.A. 86, 5562–5566 (1989).

  6. 6

    Lasky, L. A. et al. Cell 56, 1045–1055 (1989).

  7. 7

    Siegelman, M. H., van de Rijn, M. & Weissman, I. L. Science 243, 1165–1172 (1989).

  8. 8

    Lewinsohn, D. M., Bargatze, R. F. & Butcher, E. C. J. Immun. 138, 4313–4321 (1987).

  9. 9

    Jutila, M. A., Rott, L., Berg, E. L. & Butcher, E. C. J. Immun. 143, 3318–3324 (1989).

  10. 10

    Kishimoto, T. K., Jutila, M. A., Berg, E. L. & Butcher, E. C. Science 245, 1238–1241 (1989).

  11. 11

    Ord, D. C. et al. J. biol. Chem. 265, 7760–7767 (1990).

  12. 12

    Griffin, J. D. et al. J. Immun. 145, 576–584 (1990).

  13. 13

    Rosen, S. D., Singer, M. S., Yednock, Y. A. & Stoolman, L. M. Science 228, 1005–1007 (1985).

  14. 14

    Yednock, T. A., Stoolman, L. M. & Rosen, S. D. J. Cell Biol. 104, 713–723 (1987).

  15. 15

    Rosen, S. D., Chi, S. I., True, D. D., Singer, M. S. & Yednock, T. A. J. Immun. 142, 1895–1902 (1989).

  16. 16

    Stoolman, L. M., Yednock, T. A. & Rosen, S. D. Blood 70, 1842–1850 (1987).

  17. 17

    Hamann, A. et al. J. Immun. 140, 693–699 (1988).

  18. 18

    Spertini, O. et al. Leukemia (in the press).

  19. 19

    Meuer, S. C. et al. Cell 36, 897–906 (1984).

  20. 20

    Jutila, M. A., Kishimoto, T. K., & Butcher, E. C. Blood 76, 178–183 (1990).

  21. 21

    Rouis, M., Thomopoulos, P., Haziot, A. & Broquet, C. Expl Cell Res. 164, 556–561 (1986).

  22. 22

    Moon, S. O., Palfrey, H. C. & King, A. C. Proc. natn. Acad. Sci. U.S.A. 81, 2298–2302 (1984).

  23. 23

    Van der Geer, P. & Hunter, H. Molec. cell. Biol. 10, 2291–3002 (1990).

  24. 24

    Huckle, W. R., McArdle, C. A. & Conn, P. M. J. biol. Chew. 263, 3296–3302 (1988).

  25. 25

    Jalkanen, S. T. & Butcher, E. C. Blood 66, 577–582 (1985).

  26. 26

    Dustin, M. L. & Springer, T. A. Nature 341, 619–624 (1989).

  27. 27

    Shimizu, Y., Van Seventer, G. A., Horgan, K. J. & Shaw, S. Nature 345, 250–255 (1990).

  28. 28

    Glabe, C. G., Yednock, T. & Rosen, S. D. J. Cell Sci. 61, 475–490 (1983).

  29. 29

    Calvo, J. C., Radicella, J. P. & Charreau, E. H. Biochem. J. 212, 259–264 (1983).

  30. 30

    Bowen, B. R., Fennie, C. & Lasky, L. A. J. Cell Biol. 110, 147–153 (1990).

Download references

Author information

Rights and permissions

Reprints and Permissions

About this article

Further reading

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.